FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans Ibsen

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Stanley S Franklin; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Tatiana Kuznetsova; Yan Li; Lars Lind; Yanping Liu; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kei Asayama; Kristina Björklund-Bodegård; José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky
Masked hypertension in diabetes mellitus: treatment implications for clinical practice.
Rudolph Schutte; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kei Asayama; Kristina Björklund-Bodegård; José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Masahiro Kikuya; Tatiana Kuznetsova; Yan Li; Lars Lind; Yan-Ping Liu; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya
Double product reflects the predictive power of systolic pressure in the general population: evidence from 9,937 participants.
José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Masahiro Kikuya; Tatiana Kuznetsova; Yan Li; Lars Lind; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya; Emma Schwedt; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kristina Björklund-Bodegård
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans Ibsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Stanley S Franklin; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Tatiana Kuznetsova; Yan Li; Lars Lind; Yanping Liu; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kei Asayama; Kristina Björklund-Bodegård; José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky
Masked hypertension in diabetes mellitus: treatment implications for clinical practice.
Hypertension 2013;61(5):964-71.
2013: Rudolph Schutte; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kei Asayama; Kristina Björklund-Bodegård; José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Masahiro Kikuya; Tatiana Kuznetsova; Yan Li; Lars Lind; Yan-Ping Liu; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya
Double product reflects the predictive power of systolic pressure in the general population: evidence from 9,937 participants.
American journal of hypertension 2013;26(5):665-72.
2013: José Boggia; Edoardo Casiglia; Eamon Dolan; Jan Filipovsky; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Masahiro Kikuya; Tatiana Kuznetsova; Yan Li; Lars Lind; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya; Emma Schwedt; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kristina Björklund-Bodegård
Risk stratification by 24-hour ambulatory blood pressure and estimated glomerular filtration rate in 5322 subjects from 11 populations.
Hypertension 2013;61(1):18-26.
2012: Julie K K Vishram; Anne H Andreasen; Anders Borglykke; Grazyna Broda; Giancarlo Cesana; Chiara Donfrancesco; Simona Giampaoli; Hans Ibsen; Jørgen Jeppesen; Torben Jørgensen; Frank Kee; Kari Kuulasmaa; Giuseppe Mancia; Michael H Olsen; Luigi Palmieri; Susana Sans
Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project.
Hypertension 2012;60(5):1117-23.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.
Journal of hypertension 2012;30(10):1928-36.
2012: Anne Christine H Ruwald; Thomas Sehestedt; Kristian Wachtell; Bo Westergaard; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Michael H Olsen
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of hypertension 2012;30(6):1252-9.
2012: Sverre E Kjeldsen; Jan Ostergren; Bertram Pitt; Jaakko Tuomilehto; Eric J Velazquez; Michael Weber; Dion Zappe; George L Bakris; Björn Dahlöf; Allen Hester; Tsushung A Hua; Hans Ibsen; Kenneth A Jamerson; Roxzana Y Kelly
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
Blood pressure 2012;21(2):82-7.
2012: Hannah Elena Suhrs; Hans Ibsen
[Angio-oedema and medication that interferes with the renin-angiotensin-aldosterone system--a systematic review].
Ugeskrift for laeger 2012;174(11):724-9.
2012: Stanley S Franklin; Tine W Hansen; Hans Ibsen; Yutaka Imai; Jørgen Jeppesen; Kalina Kawecka-Jaszcz; Masahiro Kikuya; Tatiana Kuznetsova; Yan Li; Lars Lind; Sofia Malyutina; Yuri Nikitin; Eoin O'Brien; Takayoshi Ohkubo; Edgardo Sandoya; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Lutgarde Thijs; Valérie Tikhonoff; Christian Torp-Pedersen; Jiguang Wang; Kristina Björklund-Bodegård; José Boggia; Edoardo Casiglia; Eamon Dolan
Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population.
Hypertension 2012;59(3):564-71.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?
Journal of hypertension 2012;30(3):513-21.
2012: Lotte Usinger; Christina Reimer; Hans Ibsen
Fermented milk for hypertension.
Cochrane database of systematic reviews (Online) 2012;4():CD008118.
2011: Thomas Sehestedt; Tine W Hansen; Yan Li; Tom Richart; Jose Boggia; Masahiro Kikuya; Lutgarde Thijs; Katarzyna Stolarz-Skrzypek; Edoardo Casiglia; Valérie Tikhonoff; Sofia Malyutina; Yuri Nikitin; Kristina Björklund-Bodegård; Tatiana Kuznetsova; Takayoshi Ohkubo; Lars Lind; Christian Torp-Pedersen; Jørgen Jeppesen; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Jan A Staessen
Are blood pressure and diabetes additive or synergistic risk factors? Outcome in 8494 subjects randomly recruited from 10 populations.
Hypertension research : official journal of the Japanese Society of Hypertension 2011;34(6):714-21.
2011: Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars Lindholm; Sverre E Kjeldsen; Per Omvik; Markku S Nieminen; Björn Dahlöf; Peter M Okin; Richard B Devereux
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy.
Journal of hypertension 2011;29(5):997-1004.
2011: José Boggia; Lutgarde Thijs; Tine W Hansen; Yan Li; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Agnieszka Olszanecka; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Gladys Maestre; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women.
Hypertension 2011;57(3):397-405.
2010: Kristian Wachtell; Vittorio Palmieri; Eva Gerdts; Jonathan Bella; Gerard P Aurigemma; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Hans Ibsen; Jens E Rokkedal; Richard B Devereux
Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).
The American journal of cardiology 2010;106(7):999-1005.
2010: Hong-Qi Fan; Yan Li; Lutgarde Thijs; Tine W Hansen; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Hans Ibsen; Eoin O'Brien; Jiguang Wang; Jan A Staessen
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations.
Journal of hypertension 2010;28(10):2036-45.
2010: L Usinger; L T Jensen; B Flambard; Allan Linneberg; Hans Ibsen
The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension.
Journal of human hypertension 2010;24(10):678-83.
2010: Christina Ellervik; Anne Tybjaerg-Hansen; Merete Appleyard; Hans Ibsen; Børge G Nordestgaard
Haemochromatosis genotype and iron overload: association with hypertension and left ventricular hypertrophy.
Journal of internal medicine 2010;268(3):252-64.
2010: Jørgen Jeppesen; Tine W Hansen; Christian Torp-Pedersen; Sten Madsbad; Hans Ibsen; Torben Jørgensen; Mogens Fenger
Relationship between common lipoprotein lipase gene sequence variants, hyperinsulinemia, and risk of ischemic heart disease: A population-based study.
Atherosclerosis 2010;211(2):506-11.
2010: Yan Li; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; José Boggia; Tom Richart; Hirohito Metoki; Takayoshi Ohkubo; Christian Torp-Pedersen; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Hans Ibsen; Yutaka Imai; Jiguang Wang; Jan A Staessen
Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations.
Hypertension 2010;55(4):1040-8.
2010: Tine W Hansen; Lutgarde Thijs; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations.
Hypertension 2010;55(4):1049-57.
2010: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Christian Torp-Petersen; Per Hildebrandt; Michael H Olsen
Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
European heart journal 2010;31(7):883-91.
2010: Lotte Usinger; Hans Ibsen; Allan Linneberg; Michel Azizi; Bénédicte Flambard; Lars T Jensen
Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk.
Clinical physiology and functional imaging 2010;30(2):162-8.
2010: Børge G Nordestgaard; Kimmo Kontula; Marianne Benn; Björn Dahlöf; Ulf de Faire; Jonathan M Edelman; Erik Eliasson; Frej Fyhrquist; Darcy A Hille; Hans Ibsen; Paulette A Lyle; Kåre Berg; Mia Sandberg; Amar A Sethi; Peggy H Wong; Ingrid Os
Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study.
Pharmacogenetics and genomics 2010;20(2):77-85.
2009: Lotte Usinger; Hans Ibsen; Lars T Jensen
Does fermented milk possess antihypertensive effect in humans?
Journal of hypertension 2009;27(6):1115-20.
2009: Michael H Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Giovanni de Simone; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Sverre E Kjeldsen; Richard B Devereux; Darcy A Hille; Paulette A Lyle; Björn Dahlöf; Stevo Julius; Jonathan M Edelman; Steven M Snapinn; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
Blood pressure 2009;18(6):348-61.
2008: Ahmet Adiyaman; Dirk G Dechering; José Boggia; Yan Li; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Lutgarde Thijs; Christian Torp-Pedersen; Takayoshi Ohkubo; Eamon Dolan; Yutaka Imai; Edgardo Sandoya; Hans Ibsen; Jiguang Wang; Lars Lind; Eoin O'Brien; Theo Thien; Jan A Staessen
Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations.
Hypertension 2008;52(6):1038-44.
2008: Michael H Olsen; T W Hansen; M K Christensen; F Gustafsson; S Rasmussen; Kristian Wachtell; Hans Ibsen; C Torp-Pedersen; Per Hildebrandt
Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
Journal of human hypertension 2008;22(9):634-40.
2008: Tine W Hansen; Lutgarde Thijs; José Boggia; Yan Li; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Lars Lind; Edgardo Sandoya; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Prognostic value of ambulatory heart rate revisited in 6928 subjects from 6 populations.
Hypertension 2008;52(2):229-35.
2008: Anders Borglykke; Charlotta Pisinger; Torben Jørgensen; Hans Ibsen
The effectiveness of smoking cessation groups offered to hospitalised patients with symptoms of exacerbations of chronic obstructive pulmonary disease (COPD).
The clinical respiratory journal 2008;2(3):158-65.
2008: Yan Li; José Boggia; Lutgarde Thijs; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Tatiana Kuznetsova; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jiguang Wang; Edgardo Sandoya; Eoin O'Brien; Jan A Staessen
Is blood pressure during the night more predictive of cardiovascular outcome than during the day?
Blood pressure monitoring 2008;13(3):145-7.
2008: Tine W Hansen; Masahiro Kikuya; Lutgarde Thijs; Yan Li; José Boggia; Kristina Björklund-Bodegârd; Christian Torp-Pedersen; Jørgen Jeppesen; Hans Ibsen; Jan A Staessen
Diagnostic thresholds for ambulatory blood pressure moving lower: a review based on a meta-analysis-clinical implications.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(5):377-81.
2008: Nahid Shahmarvand; Per Løgstrup Poulsen; Hans Ibsen
[Is there an unrecognized epidemic of primary aldosteronism? The Danish Society of Hypertension].
Ugeskrift for laeger 2008;170(12):1030.
2008: Peter M Okin; Kristian Wachtell; Richard B Devereux; Markku S Nieminen; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
American journal of hypertension 2008;21(3):273-9.
2008: Sverre E Kjeldsen; Kenneth A Jamerson; George L Bakris; Bertram Pitt; Björn Dahlöf; Eric Velazquez; Jitendra Gupte; Linda Staikos; Tsushung Hua; Victor Shi; Allen Hester; Jaakko Tuomilehto; Jan Ostergren; Hans Ibsen; Michael Weber
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Blood pressure 2008;17(1):7-17.
2008: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Journal of hypertension 2008;26(1):26-34.
2007: Masahiro Kikuya; Tine W Hansen; Lutgarde Thijs; Kristina Björklund-Bodegård; Tatiana Kuznetsova; Takayoshi Ohkubo; Tom Richart; Christian Torp-Pedersen; Lars Lind; Hans Ibsen; Yutaka Imai; Jan A Staessen
Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk.
Blood pressure monitoring 2007;12(6):393-5.
2007: Giovanni de Simone; Michael H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Hans Ibsen; Sverre E Kjeldsen; Paulette A Lyle; Richard B Devereux
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
Journal of human hypertension 2007;21(8):625-32.
2007: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
European heart journal 2007;28(11):1374-81.
2007: Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen; Sten Madsbad
Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
Journal of the American College of Cardiology 2007;49(21):2112-9.
2007: Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Katherine E Harris; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Darcy A Hille; Björn Dahlöf
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current medical research and opinion 2007;23(2):259-70.
2007: Lia E Bang; Niels Wiinberg; Kristian Wachtell; John Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Hans Ibsen
Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy.
Blood pressure 2007;16(6):392-7.
2006: Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen
Metabolic syndrome, low-density lipoprotein cholesterol, and risk of cardiovascular disease: a population-based study.
Atherosclerosis 2006;189(2):369-74.
2006: Michael H Olsen; Kristian Wachtell; Björn Dahlöf; R B Devereux; Hans Ibsen; S E Kjeldsen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Journal of human hypertension 2006;20(6):460-4.
2006: Michael H Olsen; Marina K Christensen; Tine W Hansen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
Journal of hypertension 2006;24(4):655-61.
2006: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Sverre E Kjeldsen; Hans Ibsen; Ying Wan; Stevo Julius
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl E Mogensen; Björn Dahlöf; Steven M Snapinn; Ying Wan; Paulette A Lyle
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.
Diabetes care 2006;29(3):595-600.
2006: Thomas Drivsholm; Lene Falgaard Eplov; Michael Davidsen; Torben Jørgensen; Hans Ibsen; hanne hollnagel; Knut Borch-Johnsen
Representativeness in population-based studies: a detailed description of non-response in a Danish cohort study.
Scandinavian journal of public health 2006;34(6):623-31.
2006: Marina K Christensen; Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Jens Rokkedal; Hans Ibsen
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.
Blood pressure 2006;15(4):198-206.
2005: Andreas Kjaer; Christian Meyer; Kristian Wachtell; Michael H Olsen; Hans Ibsen; Lionel Opie; Søren Holm; Birger Hesse
Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
The American journal of cardiology 2005;96(12):1692-8.
2005: Albert A Carr; Peter R Kowey; Richard B Devereux; Barry M Brenner; Björn Dahlöf; Hans Ibsen; Lars H Lindholm; Paulette A Lyle; Steven M Snapinn; Zhongxin Zhang; Jonathan Edelman; Shahnaz Shahinfar
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.
The American journal of cardiology 2005;96(11):1530-6.
2005: Sverre E Kjeldsen; Paulette A Lyle; Andrew M Tershakovec; Richard B Devereux; Suzanne Oparil; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Hans Wedel
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert opinion on emerging drugs 2005;10(4):729-45.
2005: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Hypertension 2005;46(4):660-6.
2005: Eigil Fossum; andreas moan; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; Steven M Snapinn; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Björn Dahlöf
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per R Hildebrandt
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Journal of hypertension 2005;23(5):1083-90.
2005: Giovanni de Simone; Kristian Wachtell; Vittorio Palmieri; Darcy A Hille; Gareth Beevers; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Richard B Devereux
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Frej Fyhrquist; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Darcy A Hille; Paulette A Lyle; Jonathan Edelman; Steven M Snapinn; Hans Wedel
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Michael H Olsen; Eigil Fossum; Aud Høieggen; Kristian Wachtell; Elsa Hjerkinn; Shawna D Nesbitt; Ulrik B Andersen; Robert A Phillips; Cynthia L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Tine W Hansen; Jørgen Jeppesen; Susanne Rasmussen; Hans Ibsen; Christian Torp-Pedersen
Ambulatory blood pressure and mortality: a population-based study.
Hypertension 2005;45(4):499-504.
2005: Michael H Olsen; Marina K Christensen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Journal of human hypertension 2005;19(4):301-7.
2005: Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Katherine E Harris; Hans Wedel
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Marina Christensen; Hans Ibsen; René Worck
Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
Clinical science (London, England : 1979) 2005;108(2):113-9.
2005: Michael H Olsen; Kristian Wachtell; Keld Neland; Jonathan Bella; Jens Rokkedal; Harriet Dige-Petersen; Hans Ibsen
Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.
Blood pressure 2005;14(3):177-83.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vittorio Palmieri; Markku S Nieminen; Gunnar Smith; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
The American journal of cardiology 2005;95(1):132-6.
2005: Jorge R Kizer; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan Edelman; Steven M Snapinn; Katherine E Harris; Richard B Devereux
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study.
Kidney international. Supplement 2004;(92):S56-8.
2004: Kristian Wachtell; Vasilios Papademetriou; Gunnar Smith; Eva Gerdts; Björn Dahlöf; Erik Engblom; Gerard P Aurigemma; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
American heart journal 2004;148(3):538-44.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per Hildebrandt
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
Journal of hypertension 2004;22(8):1597-604.
2004: Henrik M Reims; Sverre E Kjeldsen; W E Brady; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; G Smith; Markku S Nieminen; B Dahlöf; Hans Ibsen; Richard B Devereux
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):453-9.
2004: Niels Wiinberg; Lia E Bang; Kristian Wachtell; J Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Jens Rokkedal; Hans Ibsen; Richard B Devereux
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy.
Journal of human hypertension 2004;18(6):391-6.
2004: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Michael H Olsen; Kristian Wachtell; G de Simone; Vittorio Palmieri; Harriet Dige-Petersen; Richard B Devereux; Hans Ibsen; Jens Rokkedal
Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? A LIFE substudy.
Journal of human hypertension 2004;18(6):437-43.
2004: Michael H Olsen; Kristian Wachtell; Christian Meyer; Jens D Hove; Vittorio Palmieri; Harriet Dige-Petersen; Jens Rokkedal; Birger Hesse; Hans Ibsen
Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):445-52.
2004: Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Henrik M Reims; Suzanne Oparil; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; William E Brady; Frej Fyhrquist; Hans Ibsen; Lars H Lindholm; Per Omvik; Hans Wedel; Gareth Beevers; Ulf de Faire; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Björn Dahlöf
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Richard B Devereux; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Peter Aurup; Gareth Beevers; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Sigrid Helle Berg; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Michael H Olsen; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Jonathan Bella; Shawna D Nesbitt; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius; Hans Ibsen
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Ulrik B Andersen; Michael H Olsen; Harriet Dige-Petersen; Hans Ibsen
Exercise blood pressure is related to insulin resistance in subjects with two hypertensive parents.
Blood pressure 2003;12(5-6):314-8.
2002: Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Erik Frandsen; Harriet Dige-Petersen; Jens Rokkedal; Richard B Devereux; Hans Ibsen
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American heart journal 2002;144(3):530-7.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2002;15(5):398-404.
2002: Philip Hasbak; L T Jensen; Hans Ibsen
Hypertension and renovascular disease: follow-up on 100 renal vein renin samplings.
Journal of human hypertension 2002;16(4):275-80.
2002: Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Kristian Wachtell; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Markku S Nieminen; Peter M Okin; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2002;20(3):405-12.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Jonathan Bella; Tapio Aalto; Björn Dahlöf; Eva Gerdts; Jackson T Wright; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen; Richard B Devereux
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
American heart journal 2002;143(2):319-26.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy.
Blood pressure 2002;11(5):285-92.
2001: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Ulrik B Andersen; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Maximal exercise capacity is related to cardiovascular structure in patients with longstanding hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2001;14(12):1205-10.
2001: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Richard B Devereux; Harriet Dige-Petersen; Hans Ibsen
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.
American journal of hypertension 2001;14(9 Pt 1):861-7.
2001: RH Worck; Dennis Staahltoft; Thomas E N Jonassen; Erik Frandsen; Hans Ibsen; Jørgen Søberg Petersen
Brain angiotensin receptors and sympathoadrenal regulation during insulin-induced hypoglycemia.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(4):R1162-8.
2001: Ulrik B Andersen; F Steensgaard-Hansen; Jens Rokkedal; Hans Ibsen; Harriet Dige-Petersen
Left ventricular structure and diastolic function in subjects with two hypertensive parents.
Blood pressure 2001;10(4):193-8.
2001: Kristian Wachtell; Jens Rokkedal; Jonathan Bella; Tapio Aalto; Björn Dahlöf; G Smith; Mary J Roman; Hans Ibsen; Gerard P Aurigemma; Richard B Devereux
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
The American journal of cardiology 2001;87(1):54-60.
2000: Sverre E Kjeldsen; Björn Dahlöf; R B Devereux; Stevo Julius; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: Kristian Wachtell; G Smith; Eva Gerdts; Björn Dahlöf; Markku S Nieminen; Vasilios Papademetriou; Jonathan Bella; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.
The American journal of cardiology 2000;85(4):466-72.
2000: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Blood pressure 2000;9(2-3):132-9.
2000: Michael H Olsen; Eigil Fossum; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Shawna D Nesbitt; Ulrik B Andersen; R A Phillips; C L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
2000: Kristian Wachtell; Jonathan Bella; P R Liebson; Eva Gerdts; Björn Dahlöf; Tapio Aalto; Mary J Roman; Vasilios Papademetriou; Hans Ibsen; Jens Rokkedal; Richard B Devereux
Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.
Hypertension 2000;35(1 Pt 1):6-12.
1999: Ulrik B Andersen; Peter Skøtt; Niels Eske Bruun; Harriet Dige-Petersen; Hans Ibsen
Renal effects of hyperinsulinaemia in subjects with two hypertensive parents.
Clinical science (London, England : 1979) 1999;97(6):681-7.
1999: Ulrik B Andersen; Harriet Dige-Petersen; Hans Ibsen; Peter Skøtt; Niels Eske Bruun; H Vestergaard; C Christiansen
Insulin resistance, exercise capacity and body composition in subjects with two hypertensive parents.
Journal of hypertension 1999;17(9):1273-80.
1999: J Jensen; A Lendorf; H Stimpel; J Frost; Hans Ibsen; P Rosenkilde
The prevalence and etiology of impotence in 101 male hypertensive outpatients.
American journal of hypertension 1999;12(3):271-5.
1999: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
Influence of non-steady state during isoglycemic hyperinsulinemic clamp in hypertension. A LIFE substudy.
Blood pressure 1999;8(4):207-13.
1998: Björn Dahlöf; Richard B Devereux; Stevo Julius; Sverre E Kjeldsen; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: RH Worck; Erik Frandsen; Hans Ibsen; Jørgen Søberg Petersen
AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia.
Hypertension 1998;31(1 Pt 2):384-90.
1997: Ulrik B Andersen; Harriet Dige-Petersen; Erik Frandsen; Hans Ibsen; Aage Voelund
Basal insulin-level oscillations in normotensive individuals with genetic predisposition to essential hypertension exhibit an irregular pattern.
Journal of hypertension 1997;15(10):1167-73.
1997: Björn Dahlöf; R Devereux; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: RH Worck; Hans Ibsen; Erik Frandsen; Harriet Dige-Petersen
AT1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans.
The American journal of physiology 1997;272(3 Pt 1):E415-21.
1997: Michael Ottesen; R Worck; Hans Ibsen
Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans.
Blood pressure 1997;6(1):29-34.
1996: Hans Ibsen; S Rasmussen; R Slatanach
[Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
Ugeskrift for laeger 1996;158(26):3798-802.
1996: K Wachtell; Hans Ibsen; M H Olsen; C Laybourn; Jens Krogh Christoffersen; H Nørgaard; Margit Mantoni; J O Lund
Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension.
Journal of human hypertension 1996;10(2):83-5.
1995: JO Clausen; Hans Ibsen; Harriet Dige-Petersen; K Borch-Johnsen; O Pedersen
The importance of adrenaline, insulin and insulin sensitivity as determinants for blood pressure in young Danes.
Journal of hypertension 1995;13(5):499-505.
1995: R H Worck; Hans Ibsen; C B Andersen; K K Ibsen; F Rasmussen
The etiology of hypertension in nonrenovascular unilateral renal disease--two cases of renin induced hypertension in congenital renal dysplasia.
Blood pressure 1995;4(2):113-6.
1988: Niels Eske Bruun; Hans Ibsen; Peter Skøtt; D Toftdahl; J Giese; Niels-Henrik Holstein-Rathlou
Lithium clearance and renal tubular sodium handling during acute and long-term nifedipine treatment in essential hypertension.
Clinical science (London, England : 1979) 1988;75(6):609-13.
1986: Niels Eske Bruun; Hans Ibsen; F Nielsen; M D Nielsen; A G Moelbak; O J Hartling
Lack of effect of nifedipine on counterregulatory mechanisms in essential hypertension.
Hypertension 1986;8(8):655-61.
1986: U G Svendsen; Hans Ibsen; S Rasmussen; A Leth; M D Nielsen; Harriet Dige-Petersen; J Giese
Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
European journal of clinical pharmacology 1986;30(2):151-6.
1986: S Rasmussen; A Leth; Hans Ibsen; M Damkjaer Nielsen; F Nielsen; J Giese
Converting enzyme inhibition in mild and moderate essential hypertension. II.
Acta medica Scandinavica 1986;219(1):29-36.
1985: Niels Eske Bruun; Hans Ibsen; F Nielsen; M D Nielsen; A G Mølbak; O J Hartling
The influence of nifedipine treatment on counter-regulatory mechanisms in essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S223-5.
1985: S Rasmussen; A Leth; Hans Ibsen; M Damkjaer Nielsen; F Nielsen; J Giese
Converting enzyme inhibition in mild and moderate essential hypertension. I. Acute effects on blood pressure, the renin-angiotensin system and blood bradykinin after a single dose of captopril.
Acta medica Scandinavica 1985;218(5):435-42.
1984: S Rasmussen; M Damkjaer Nielsen; Hans Ibsen; A Leth; J Giese
The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
European journal of clinical investigation 1984;14(1):30-6.
1983: U G Svendsen; Hans Ibsen; S Rasmussen; A Leth; M D Nielsen; Harriet Dige-Petersen; J Giese
Effects of amiloride on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in thiazide-treated hypertensive patients.
Clinical pharmacology and therapeutics 1983;34(4):448-53.
1983: M Damkjaer Nielsen; J Giese; B Hesse; S Rasmussen; Hans Ibsen
Inactive renin in renal venous blood: biological, methodological and statistical aspects.
Acta medica Scandinavica. Supplementum 1983;677():80-4.
1983: S Rasmussen; A Leth; Hans Ibsen; M Damkjaer Nielsen; F Nielsen; J Giese
Captopril in mild and moderate essential hypertension: physiological and biochemical monitoring.
Acta medica Scandinavica. Supplementum 1983;677():105-9.
1981: Hans Ibsen; N J Christensen; S Rasmussen; hanne hollnagel; M Damkjaer Nielsen; J Giese
The influence of chronic high alcohol intake on blood pressure, plasma noradrenaline concentration and plasma renin concentration.
Clinical science (London, England : 1979) 1981;61 Suppl 7():377s-379s.
1980: Hans Ibsen; N J Christensen; hanne hollnagel; A Leth; A M Kappelgaard; J Giese
Plasma noradrenaline concentration in hypertensive and normotensive forty-year-old individuals: relationship to plasma renin concentration.
Scandinavian journal of clinical and laboratory investigation 1980;40(4):333-9.
1980: Hans Ibsen; A Leth; A McNair; N J Christensen; J Giese
Angiotensin II blockade during combined thiazide-beta-blocker treatment.
Scandinavian journal of clinical and laboratory investigation 1980;40(4):325-31.
1980: Hans Ibsen; J Giese; A Rabøl; A M Kappelgaard
The use of an angiotensin II antagonist (saralasin) as an adjunct during renal vein catheterization.
Scandinavian journal of clinical and laboratory investigation 1980;40(2):115-20.